# K142593: AngioVac Cannula

- Pathway: 510(k) (Traditional)
- Applicant: AngioDynamics, Inc.
- Decided: Nov 12, 2014 after 58 days
- Product code: DWF (Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass)
- Device class: 2
- Regulation: 21 CFR 870.4210
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K091304 (2009). 2 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K133445: Angiovac Cannula, Vortex Medical, Inc. (2014) Summary page 5.

## Most influential descendants
- K190594: AngioVac C20, AngioVac C180 (2019), 2 descendants of its own
- K253106: AngioVac Cannula (2025), 0 descendants of its own
- K212386: AngioVac F18 85 (2021), 0 descendants of its own

## Indications for use
The AngioVac Cannula is indicated for use as a venous drainage cannula and for removal of fresh, soft thrombi or emboli during extracorporeal bypass for up to 6 hours.

Source page: https://510kreport.com/device/K142593
Methodology: https://510kreport.com/methodology